Inventor

BARUCH KUTI

IL22 patents

⚠️ This page may combine multiple inventors who share the name “BARUCH KUTI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BARUCH KUTI

YEDA RES & DEV

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer&#39;s disease

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer&#39;s disease

Reducing systemic regulatory T cell levels or activity for treatment of alzheimer&#39;s disease

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer&#39;s disease

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer&#39;s disease

Reducing systemic regulatory T cell levels or activity for treatment of alzheimer&#39;s disease

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer&#39;s disease

Reducing systemic regulatory T cell levels or activity for treatment of alzheimer&#39;s disease

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorder

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis

Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis

Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS

IMMUNOBRAIN CHECKPOINT INC

Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative disease

Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative disease

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease

Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease

Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease